Dr. Armen Yuri Gasparyan

A Teaching Trust of University of Birmingham

Dr. Armen Yuri Gasparyan has been involved in clinical research on cardiovascular issues in inflammatory disorders since 1994, and got his PhD degree in 2002. He was a trainer of English speaking medical students (Yerevan, 2003-2008) and awarded an academic title of Associate Professor of medicine in 2006. Since 2007, he has been post-doctoral research fellow in thrombosis and cardiovascular rheumatology in the UK, supported by the European Society of Cardiology and the European League Against Rheumatism. In 2010, he was awarded title of Fellow of the European Society of Cardiology (FESC). As a clinical lecturer, he delivered lectures on the whole course of internal medicine, developed evidence-based clinical guidelines for general practitioners and a textbook on internal medicine. Over the past four years, he also organized international seminars on science editing in the UK, Turkey, Iran, and Spain. He is a reviewer at The Lancet, Atherosclerosis, Thrombosis and Haemostasis, Thrombosis Research, Journal of Human Hypertension, Rheumatology (Oxford), Seminars in Arthritis and Rheumatism, Current Pharmaceutical Design, Platelets, Rheumatology International, Academic Medicine and some other indexed journals (since 2006). He is also a guest editor of Current Pharmaceutical Design, Deputy Editor-in-Chief of Inflammation and Allergy - Drug Targets, member of editorial board of Atherosclerosis, Thrombosis Research, Vascular Health and Risk Management, Rheumatology International and Current Vascular Pharmacology. In 2007-2010, Dr A.Y.Gasparyan served as the executive editor of Archives of Medical Science (Poland), and joined the World Association of Medical Editors (2008) and the European Association of Science Editors (2009). Since 2011, he is chief editor of European Science Editing and council member of the European Association of Science Editors. A.Y. Gasparyan published numerous papers, reviews and editorials, including the following highly cited articles: 1. [Gasparyan AY, et al. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 2010;8(4):437-449. ], 2. [Gasparyan AY, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17(1):47-58. ], 3. [Gasparyan AY, et al. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 2008;51(19):1829-1843.].

Experience

  • 2008 - current

    A Teaching Trust of University of Birmingham

    Research projects on cardiovascular disease in inflammatory disorders and science editing

  • 2007 - 2008

    University of Birmingham

    Research project on platelet function in cardiovascular disease, heart failure and anti-platelet therapy

  • 2011 - current

    European Association of Science Editors

  • 2003 - 2008

    Yerevan State Medical University

  • 1999 - 2003

    The World Bank

Education

  • 1990 - 1997

    General Medicine, Yerevan State Medical University, Yerevan

    Internal Medicine

  • 2002 - 2002

    Teaching Hospital, Medizinische Universität Graz, Graz

    Department of Internal Medicine, Krankenhaus der Barmherzigen Brüder

  • 2000 – 2002

    General Medicine, Yerevan State Medical University, Yerevan

    Internal Medicine

Edited Books

  • Cardiovascular Risk Factors

    Cardiovascular risk factors contribute to the development of cardiovascular disease from early life. It is thus crucial to implement preventive strategies addressing the burden of cardiovascular disease as early as possible. A multidisciplinary approach to the risk estimation and prevention of vascular events should be adopted at each level of health care, starting from the setting of perinatology. Recent decades have been marked with major advances in this field, with the emergence of a variety of new inflammatory and immune-mediated markers of heightened cardiovascular risk in particular. The current book reflects some of the emerging concepts in cardiovascular pathophysiology and the shifting paradigm of cardiovascular risk estimation. It comprehensively covers primary and secondary preventive measures targeted at different age and gender groups. Attention is paid to inflammatory and metabolic markers of vascular damage and to the assessment of vascular function by noninvasive standardized ultrasound techniques. This is a must-read book for all health professionals and researchers tackling the issue of cardiovascular burden at individual and community level. It can also serve as a didactic source for postgraduate medical students.